ContraFect Gains with Key Data Presentation Set for Next Week
Market News

ContraFect Gains with Key Data Presentation Set for Next Week

Shares of biotechnology company ContraFect Corp. (NASDAQ:CFRX) are up a massive 42.3% in the morning session today after it was selected to present four posters at the ASM Microbe Conference in Houston, Texas between June 15 to 19.

The company’s data presentation will include CF-370 showcasing ‘efficacious activity in a neutropenic rabbit pneumonia model against an extensively-drug-resistant (XDR) strain of Klebsiella pneumoniae.

Every year, about 700,000 deaths across the globe are related to antimicrobial-resistant infections. ContraFect is focused on applying product candidates developed from its proprietary platform towards addressing life-threatening infections.

The company is presently enrolling subjects in a Phase 1b/2 study of exebacase ‘in the setting of a DAIR procedure’ for chronic prosthetic joint infections of the knee caused by S. aureus or coagulase-Negative Staphylococci (CoNS).

With today’s price gains, ContraFect shares have now jumped about 40.7% over the past five sessions.

Read full Disclosure

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
RUT
Russell 2000
TNX
10-Yr-Bond
Bitcoin

Popular Articles